Fingerpaint Group is biopharma’s global commercialization partner for analytics-enabled integrated solutions. At its core is an award-winning global team of almost 800 people who are committed to creating and executing meaningful brand experiences for healthcare providers, care partners, and patients.
Like our Company, the Knox Lane team has a strong sense of culture and values. We could not have picked a better partner as we seek to level up our game in talent, digital, and expansion of our capabilities into other commercialization areas.Ed Mitzen, Founder and CEO, Fingerpaint Group